http://www.aktiencheck.de aktiencheck.de aktiencheck.de Sat, 18 Apr 2026 16:33:18 +0200 2 http://www.aktiencheck.de/forum/MindMed_Psychedelika_gegen_Abhaengigkeiten-A420P3-t570023 http://www.aktiencheck.de/forum/MindMed_Psychedelika_gegen_Abhaengigkeiten-A420P3-t570023 Mindmedicine wird es mit Psilocybin schwer haben, Wettbewerb demnach ist leider besser. Vocan von Core One meldet internationales Patent für seine bahnbrechende proprietäre biosynthetische Psilocybin-Produktionsmethode an. Quelle: https://core1labs. [<a href="http://www.aktiencheck.de/forum/MindMed_Psychedelika_gegen_Abhaengigkeiten-A420P3-t570023">mehr</a>] http://www.aktiencheck.de/forum/Broadway_Mining_strotzt_vor_Selbstvertrauen-A420P3-t543774 http://www.aktiencheck.de/forum/Broadway_Mining_strotzt_vor_Selbstvertrauen-A420P3-t543774 MNMD joins CTTi as member of Steering Commitee, Zitat:"MindMed joins CTTI as one of approximately 80 member organizations interested in advancing higher quality clinical trials and accelerating the path to new therapeutics and other medical products. CTTI convenes its members – along with nearly 500+ multi-stakeholder organizations and individuals from across the clinical trials ecosystem – to discuss issues, exchange ideas, and come to a consensus on solutions to the greatest challenges in clinical research. As a member of the Steering Committee, MindMed will contribute to setting project priorities within CTTI's agenda, as well as serving on the teams that create recommendations and resources to transform clinical trials globally....:" ENDE Zitat Quelle:https://www.stockwatch. [<a href="http://www.aktiencheck.de/forum/Broadway_Mining_strotzt_vor_Selbstvertrauen-A420P3-t543774">mehr</a>]